Holtec Nuclear Corporation launched its IPO roadshow on September 8, 2026, pricing 50 million Class A shares at $15–$18 to raise up to $900 million and implying a $8.5–$10.2 billion valuation range at the high end on a fully exchanged basis of roughly 567 million shares. The midpoint equates to about $9.35 billion, with net proceeds earmarked for SMR-300 licensing, Palisades restart execution, and manufacturing expansion amid surging AI-driven power demand. Recent financials show TTM revenue near $560 million and variable net income, bolstered by DOE grants and legacy nuclear services but tempered by a dual-class structure granting public shares minimal voting power. With pricing expected the week of September 14 and trading slated for around September 18, trader sentiment on the closing market cap clusters tightly around $10–12 billion, reflecting uncertainty over debut performance, sector volatility, and execution risks on first-of-a-kind SMR deployment.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour10-11 milliards de dollars 41%
9-10 milliards de dollars 36%
12-13 milliards de dollars 30%
<9 milliards $ 27%
<9 milliards $
27%
9-10 milliards de dollars
36%
10-11 milliards de dollars
41%
11 à 12 milliards de dollars
26%
12-13 milliards de dollars
30%
13 Mds $-14 Mds $
19%
14 G$ et plus
11%
Aucune introduction en bourse avant novembre 2026
21%
10-11 milliards de dollars 41%
9-10 milliards de dollars 36%
12-13 milliards de dollars 30%
<9 milliards $ 27%
<9 milliards $
27%
9-10 milliards de dollars
36%
10-11 milliards de dollars
41%
11 à 12 milliards de dollars
26%
12-13 milliards de dollars
30%
13 Mds $-14 Mds $
19%
14 G$ et plus
11%
Aucune introduction en bourse avant novembre 2026
21%
As of market creation, the IPO is scheduled to price on September 17 (ET). If no such IPO occurs by October 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before November 2026".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency.
It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day.
If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently.
The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page.
If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket.
The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading.
In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.
Marché ouvert : Sep 8, 2026, 7:55 PM ET
Résolveur
0x69c47De9D...As of market creation, the IPO is scheduled to price on September 17 (ET). If no such IPO occurs by October 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before November 2026".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency.
It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day.
If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently.
The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page.
If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket.
The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading.
In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.
Résolveur
0x69c47De9D...Holtec Nuclear Corporation launched its IPO roadshow on September 8, 2026, pricing 50 million Class A shares at $15–$18 to raise up to $900 million and implying a $8.5–$10.2 billion valuation range at the high end on a fully exchanged basis of roughly 567 million shares. The midpoint equates to about $9.35 billion, with net proceeds earmarked for SMR-300 licensing, Palisades restart execution, and manufacturing expansion amid surging AI-driven power demand. Recent financials show TTM revenue near $560 million and variable net income, bolstered by DOE grants and legacy nuclear services but tempered by a dual-class structure granting public shares minimal voting power. With pricing expected the week of September 14 and trading slated for around September 18, trader sentiment on the closing market cap clusters tightly around $10–12 billion, reflecting uncertainty over debut performance, sector volatility, and execution risks on first-of-a-kind SMR deployment.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour



Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes